Back to Journals » ClinicoEconomics and Outcomes Research

ClinicoEconomics and Outcomes Research


Journal Articles:

- 408 records -

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes

Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL

ClinicoEconomics and Outcomes Research 2017, 9:731-739

Published Date: 24 November 2017

Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database

Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G

ClinicoEconomics and Outcomes Research 2017, 9:711-720

Published Date: 21 November 2017

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

Lorenzoni V, Baccetti F, Genovese S, Torre E, Turchetti G

ClinicoEconomics and Outcomes Research 2017, 9:699-710

Published Date: 20 November 2017

Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results

Pradelli L, Povero M, Bürkle H, Kampmeier T, Della-Rocca G, Feuersenger A, Baron J, Westphal M

ClinicoEconomics and Outcomes Research 2017, 9:685-698

Published Date: 9 November 2017

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis

Geale K, Saridogan E, Lehmann M, Arriagada P, Hultberg M, Henriksson M

ClinicoEconomics and Outcomes Research 2017, 9:669-676

Published Date: 1 November 2017

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S

ClinicoEconomics and Outcomes Research 2017, 9:655-668

Published Date: 25 October 2017

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC

ClinicoEconomics and Outcomes Research 2017, 9:641-652

Published Date: 16 October 2017

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK

ClinicoEconomics and Outcomes Research 2017, 9:629-639

Published Date: 10 October 2017

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark

Poulsen PB, Johnsen SP, Hansen ML, Brandes A, Husted S, Harboe L, Dybro L

ClinicoEconomics and Outcomes Research 2017, 9:617-627

Published Date: 10 October 2017

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy

Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2017, 9:609-616

Published Date: 10 October 2017

Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor

Blackwell SC, Sullivan EM, Petrilla AA, Shen X, Troeger KA, Byrne JD

ClinicoEconomics and Outcomes Research 2017, 9:585-594

Published Date: 3 October 2017

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG

ClinicoEconomics and Outcomes Research 2017, 9:573-584

Published Date: 29 September 2017

Technology that achieves the Triple Aim: an economic analysis of the BrainPathTM approach  in neurosurgery

Norton SP, Dickerson EM, Kulwin CG, Shah MV

ClinicoEconomics and Outcomes Research 2017, 9:519-523

Published Date: 26 August 2017

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C

ClinicoEconomics and Outcomes Research 2017, 9:505-518

Published Date: 16 August 2017

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, Phan AT

ClinicoEconomics and Outcomes Research 2017, 9:495-503

Published Date: 16 August 2017

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

Mearns ES, Liang M, Limone BL, Gilligan AM, Miller JD, Schaum KD, Waycaster CR

ClinicoEconomics and Outcomes Research 2017, 9:485-494

Published Date: 16 August 2017

The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis

Kiatos E, Armstrong JJ, Hutnik CML, Tsioros SM, Malvankar-Mehta MS, Hodge WG

ClinicoEconomics and Outcomes Research 2017, 9:459-474

Published Date: 9 August 2017

Cost analysis of adverse events associated with non-small cell lung cancer management in France

Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E

ClinicoEconomics and Outcomes Research 2017, 9:443-449

Published Date: 27 July 2017

Cost of illness of urothelial bladder cancer in Italy

Gerace C, Montorsi F, Tambaro R, Cartenì G, De Luca S, Tucci M, Martorana G, Basso U, Cardosi L, Teruzzi C

ClinicoEconomics and Outcomes Research 2017, 9:433-442

Published Date: 24 July 2017

A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients

Lucidi C, Di Gregorio V, Ceccarelli G, Venditti M, Riggio O, Merli M

ClinicoEconomics and Outcomes Research 2017, 9:385-390

Published Date: 29 June 2017

Burden of air leak complications in thoracic surgery estimated using a national hospital billing database

Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I

ClinicoEconomics and Outcomes Research 2017, 9:373-383

Published Date: 29 June 2017

The economic and humanistic costs of chronic lower back pain in Japan

Montgomery W, Sato M, Nagasaka Y, Vietri J

ClinicoEconomics and Outcomes Research 2017, 9:361-371

Published Date: 23 June 2017

Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications

Foglia E, Ferrario L, Garagiola E, Signoriello G, Pellino G, Croce D, Canonico S

ClinicoEconomics and Outcomes Research 2017, 9:343-351

Published Date: 12 June 2017

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Adkins EM, Nicholson L, Floyd D, Ratcliffe M, Chevrou-Severac H

ClinicoEconomics and Outcomes Research 2017, 9:327-342

Published Date: 10 June 2017

In-center hemodialysis absenteeism: prevalence and association with outcomes

Gray KS, Cohen DE, Brunelli SM

ClinicoEconomics and Outcomes Research 2017, 9:307-315

Published Date: 24 May 2017

Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database

Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y

ClinicoEconomics and Outcomes Research 2017, 9:295-306

Published Date: 22 May 2017

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis

Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A

ClinicoEconomics and Outcomes Research 2017, 9:281-293

Published Date: 22 May 2017

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M

ClinicoEconomics and Outcomes Research 2017, 9:271-279

Published Date: 16 May 2017

A retrospective analysis of delays in the diagnosis of lung cancer and associated costs

Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC

ClinicoEconomics and Outcomes Research 2017, 9:261-269

Published Date: 12 May 2017

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

Degli Esposti L, Veronesi C, Perrone V, Buda S, Santoro A

ClinicoEconomics and Outcomes Research 2017, 9:233-239

Published Date: 27 April 2017

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom

Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J

ClinicoEconomics and Outcomes Research 2017, 9:211-229

Published Date: 15 April 2017

Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria

Okeahialam BN, Adeniyi MA

ClinicoEconomics and Outcomes Research 2017, 9:207-210

Published Date: 10 April 2017

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant

Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G

ClinicoEconomics and Outcomes Research 2017, 9:201-206

Published Date: 3 April 2017

Survey on attitudes of Italian pediatricians toward cough

Zanasi A, Morcaldi L, Cazzato S, Mazzolini M, Lecchi M, Morselli-Labate AM, Mastroroberto M, Dal Negro RW

ClinicoEconomics and Outcomes Research 2017, 9:189-199

Published Date: 16 March 2017

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J

ClinicoEconomics and Outcomes Research 2017, 9:163-172

Published Date: 27 February 2017

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

Brodszky V, Bíró A, Szekanecz Z, Soós B, Baji P, Rencz F, Tóthfalusi L, Gulácsi L, Péntek M

ClinicoEconomics and Outcomes Research 2017, 9:139-147

Published Date: 15 February 2017

Cost analysis of facial injury treatment in two university hospitals in Malaysia: a prospective study

Saperi BS, Ramli R, Ahmed Z, Muhd Nur A, Ibrahim MI, Rashdi MF, Nordin R, Rahman NA, Yusoff A, Nazimi AJ, Abdul Rahman R, Abdul Razak N, Mohamed N

ClinicoEconomics and Outcomes Research 2017, 9:107-113

Published Date: 7 February 2017

The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China

Shi Q, Hu S, Furnback WE, Guzauskas GF, Shen J, Wang BCM

ClinicoEconomics and Outcomes Research 2017, 9:99-106

Published Date: 3 February 2017

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

Watson C, Prosser C, Braun S, Landsman-Blumberg PB, Gleissner E, Naoshy S

ClinicoEconomics and Outcomes Research 2017, 9:85-97

Published Date: 1 February 2017

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M

ClinicoEconomics and Outcomes Research 2017, 9:77-84

Published Date: 16 February 2017

Relative cost-effectiveness of using a liquid human milk fortifier in preterm infants in the US

Guest JF, Moya F, Sisk PM, Hudak ML, Kuehn D

ClinicoEconomics and Outcomes Research 2017, 9:49-57

Published Date: 4 January 2017

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2017, 9:39-47

Published Date: 30 December 2016

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2017, 9:31-38

Published Date: 30 December 2016

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

Degli Esposti L, Favalli EG, Sangiorgi D, Di Turi R, Farina G, Gambera M, Ravasio R

ClinicoEconomics and Outcomes Research 2017, 9:9-17

Published Date: 21 December 2016

Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital

Pham LD, Phung NHT, Le NTD, Vo TQ

ClinicoEconomics and Outcomes Research 2017, 9:1-8

Published Date: 16 December 2016

Patient-reported financial barriers to adherence to treatment in neurology

Moura LMVR, Schwamm EL, Moura Junior V, Seitz MP, Hoch DB, Hsu J, Schwamm LH

ClinicoEconomics and Outcomes Research 2016, 8:685-694

Published Date: 17 November 2016

Evaluating increased resource use in fibromyalgia using electronic health records

Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S

ClinicoEconomics and Outcomes Research 2016, 8:675-683

Published Date: 16 November 2016

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW

ClinicoEconomics and Outcomes Research 2016, 8:657-666

Published Date: 31 October 2016

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:649-655

Published Date: 25 October 2016

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK

ClinicoEconomics and Outcomes Research 2016, 8:641-648

Published Date: 25 October 2016

Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil

Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L

ClinicoEconomics and Outcomes Research 2016, 8:629-639

Published Date: 19 October 2016

The direct health-care burden of valvular heart disease: evidence from US national survey data

Moore M, Chen J, Mallow PJ, Rizzo JA

ClinicoEconomics and Outcomes Research 2016, 8:613-627

Published Date: 18 October 2016

Bringing patient centricity to diabetes medication access in Canada

Glennie JL, Kovacs Burns K, Oh P

ClinicoEconomics and Outcomes Research 2016, 8:599-611

Published Date: 17 October 2016

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:591-597

Published Date: 14 October 2016

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J

ClinicoEconomics and Outcomes Research 2016, 8:583-590

Published Date: 12 October 2016

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes

Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ

ClinicoEconomics and Outcomes Research 2016, 8:559-571

Published Date: 7 October 2016

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J

ClinicoEconomics and Outcomes Research 2016, 8:541-550

Published Date: 26 September 2016

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F

ClinicoEconomics and Outcomes Research 2016, 8:531-540

Published Date: 22 September 2016

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:521-529

Published Date: 21 September 2016

A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding

Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R

ClinicoEconomics and Outcomes Research 2016, 8:507-519

Published Date: 21 September 2016

Patient-level costs of major cardiovascular conditions: a review of the international literature

Nicholson G, Gandra SR, Halbert RJ, Richhariya A, Nordyke RJ

ClinicoEconomics and Outcomes Research 2016, 8:495-506

Published Date: 21 September 2016

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J

ClinicoEconomics and Outcomes Research 2016, 8:485-493

Published Date: 19 September 2016

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2016, 8:475-484

Published Date: 21 September 2016

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

ClinicoEconomics and Outcomes Research 2016, 8:467-473

Published Date: 14 September 2016

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Thompson M, Henshall C, Garrison LP, Griffin AD, Coyle D, Long S, Khayat ZA, Anger DL, Yu R

ClinicoEconomics and Outcomes Research 2016, 8:427-433

Published Date: 26 August 2016

A systematic review of observational studies evaluating costs of adverse drug reactions

Batel Marques F, Penedones A, Mendes D, Alves C

ClinicoEconomics and Outcomes Research 2016, 8:413-426

Published Date: 24 August 2016

The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database

Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W

ClinicoEconomics and Outcomes Research 2016, 8:387-395

Published Date: 2 August 2016

Work intensity in sacroiliac joint fusion and lumbar microdiscectomy

Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:367-376

Published Date: 26 July 2016

Characterizing individual painDETECT symptoms by average pain severity

Sadosky A, Koduru V, Bienen EJ, Cappelleri JC

ClinicoEconomics and Outcomes Research 2016, 8:361-366

Published Date: 26 July 2016

The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact

De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G

ClinicoEconomics and Outcomes Research 2016, 8:317-322

Published Date: 29 June 2016

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland

Guest JF, Weidlich D, Kaczmarski M, Jarocka-Cyrta E, Kobelska-Dubiel N, Krauze A, Sakowska-Maliszewska I, Zawadzka-Krajewska A

ClinicoEconomics and Outcomes Research 2016, 8:307-316

Published Date: 28 June 2016

Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:305-306

Published Date: 27 June 2016

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?

Klag N, Walter AC, Sheely KM, Manahan KJ, Geisler JP

ClinicoEconomics and Outcomes Research 2016, 8:287-291

Published Date: 21 June 2016

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C

ClinicoEconomics and Outcomes Research 2016, 8:275-285

Published Date: 14 June 2016

A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample

Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G

ClinicoEconomics and Outcomes Research 2016, 8:267-274

Published Date: 13 June 2016

Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification

Menditto E, Bolufer de Gea A, Cahir C, Marengoni A, Riegler S, Fico G, Costa E, Monaco A, Pecorelli S, Pani L, Prados-Torres A

ClinicoEconomics and Outcomes Research 2016, 8:253-265

Published Date: 13 June 2016

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M

ClinicoEconomics and Outcomes Research 2016, 8:243-252

Published Date: 11 June 2016

Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain

García Robaina JC, Polanco Sánchez C, Estella Pérez E

ClinicoEconomics and Outcomes Research 2016, 8:235-241

Published Date: 14 June 2016

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS

ClinicoEconomics and Outcomes Research 2016, 8:215-226

Published Date: 20 May 2016

The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study

Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S

ClinicoEconomics and Outcomes Research 2016, 8:207-214

Published Date: 20 May 2016

Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable

Schmier JK, Hulme-Lowe CK, Semenova S, Klenk JA, DeLeo PC, Sedlak R, Carlson PA

ClinicoEconomics and Outcomes Research 2016, 8:197-205

Published Date: 13 May 2016

Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

Al-Ahmad M, Alowayesh MS, Carroll NV

ClinicoEconomics and Outcomes Research 2016, 8:163-169

Published Date: 10 May 2016

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

Chen W, Yang Y, Chen Y, Du F, Zhan H

ClinicoEconomics and Outcomes Research 2016, 8:137-151

Published Date: 3 May 2016

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand

Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:127-136

Published Date: 29 April 2016

A burden of illness study for neuropathic pain in Europe

Liedgens H, Obradovic M, De Courcy J, Holbrook T, Jakubanis R

ClinicoEconomics and Outcomes Research 2016, 8:113-126

Published Date: 27 April 2016

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Johnson BH, Bonafede MM, Watson C

ClinicoEconomics and Outcomes Research 2016, 8:53-61

Published Date: 23 February 2016

Costs associated with rheumatoid arthritis in Italy: past, present, and future

Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A

ClinicoEconomics and Outcomes Research 2016, 8:33-41

Published Date: 10 February 2016

Ignoring the sacroiliac joint in chronic low back pain is costly

Polly DW, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:23-31

Published Date: 21 January 2016

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A

ClinicoEconomics and Outcomes Research 2016, 8:15-21

Published Date: 31 December 2015

Cost-effectiveness of minimally invasive sacroiliac joint fusion

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:1-14

Published Date: 18 December 2015

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir

Walker DR, Juday TR, Manthena SR, Jing Y, Sood V

ClinicoEconomics and Outcomes Research 2015, 7:637-642

Published Date: 17 December 2015

Adjustment of foreign EQ-5D-3L utilities can increase their transferability

Oddershede L, Petersen KD

ClinicoEconomics and Outcomes Research 2015, 7:629-636

Published Date: 15 December 2015

Gastrointestinal events and association with initiation of treatment for osteoporosis

Modi A, Siris ES, Tang J, Sajjan S, Sen SS

ClinicoEconomics and Outcomes Research 2015, 7:603-613

Published Date: 25 November 2015

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain

Guest JF, Weidlich D, Mascuñán Díaz JI, Díaz JJ, Ojeda PM, Ferrer-González JP, Gil D, Onrubia I, Rincón Víctor P

ClinicoEconomics and Outcomes Research 2015, 7:583-591

Published Date: 23 November 2015

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

Menditto E, Orlando V, Coretti S, Putignano D, Fiorentino D, Ruggeri M

ClinicoEconomics and Outcomes Research 2015, 7:575-581

Published Date: 11 November 2015

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats

Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, Scaife JG, Rao Y, Corral M

ClinicoEconomics and Outcomes Research 2015, 7:567-574

Published Date: 6 November 2015

The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria

Olatunya OS, Ogundare EO, Fadare JO, Oluwayemi IO, Agaja OT, Adeyefa BS, Aderiye O

ClinicoEconomics and Outcomes Research 2015, 7:545-553

Published Date: 4 November 2015

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2015, 7:527-535

Published Date: 13 October 2015

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan

Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M

ClinicoEconomics and Outcomes Research 2015, 7:505-520

Published Date: 7 October 2015

Estimating the health care burden of prescription opioid abuse in five European countries

Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WCN

ClinicoEconomics and Outcomes Research 2015, 7:477-488

Published Date: 15 September 2015

Review of the cost of venous thromboembolism

Fernandez MM, Hogue S, Preblick R, Kwong WJ

ClinicoEconomics and Outcomes Research 2015, 7:451-462

Published Date: 28 August 2015

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis

Abogunrin S, Brand S, Desai K, Dinet J, Gabriel S, Harrower T

ClinicoEconomics and Outcomes Research 2015, 7:441-449

Published Date: 9 September 2015

Impact of noncommunicable diseases in the State of Qatar

Al-Kaabi SK, Atherton A

ClinicoEconomics and Outcomes Research 2015, 7:377-385

Published Date: 2 July 2015

Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition

Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL

ClinicoEconomics and Outcomes Research 2015, 7:369-375

Published Date: 26 June 2015

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan

Mandrik O, Knies S, Severens JL

ClinicoEconomics and Outcomes Research 2015, 7:347-356

Published Date: 12 June 2015

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia

Bonafede MM, Johnson BH, Richhariya A, Gandra SR

ClinicoEconomics and Outcomes Research 2015, 7:337-345

Published Date: 9 June 2015

Prevalence and cost of imaging in inpatient falls: the rising cost of falling

Fields J, Alturkistani T, Kumar N, Kanuri A, Salem DN, Munn S, Blazey-Martin D

ClinicoEconomics and Outcomes Research 2015, 7:281-286

Published Date: 3 June 2015

Adherence to statin treatment following a myocardial infarction: an Italian population-based survey

Monaldi B, Bologna G, Costa GG, D'Agostino C, Ferrante F, Filice M, Grion A, Mingarelli A, Paloscia L, Tettamanti R, Veronesi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2015, 7:273-280

Published Date: 1 June 2015

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

Tsoi B, Blackhouse G, Ferrazzi S, Reade CJ, Chen I, Goeree R

ClinicoEconomics and Outcomes Research 2015, 7:213-225

Published Date: 17 April 2015

Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis

Yang YC, Du F, Ye WY, Chen Y, Li JH, Zhang J, Nicely H, Burge R

ClinicoEconomics and Outcomes Research 2015, 7:205-212

Published Date: 13 April 2015

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

Abogunrin S, Hortobagyi L, Remak E, Dinet J, Gabriel S, Bakheit AM

ClinicoEconomics and Outcomes Research 2015, 7:185-193

Published Date: 1 April 2015

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study

Darbà J, Kaskens L, Detournay B, Kern W, Nicolucci A, Orozco-Beltrán D, Ramírez de Arellano A

ClinicoEconomics and Outcomes Research 2015, 7:163-171

Published Date: 23 March 2015

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S

ClinicoEconomics and Outcomes Research 2015, 7:153-159

Published Date: 16 March 2015

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

Darbà J, Kaskens L, Sorio Vilela F, Lothgren M

ClinicoEconomics and Outcomes Research 2015, 7:105-117

Published Date: 9 February 2015

Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies

McDonell AL, Kiiskinen U, Zammit DC, Kotchie RW, Thuresson PO, Nicolay C, Haslam T, Bruinsma M, Janszen-Van Oosterhout AJ, Otto T

ClinicoEconomics and Outcomes Research 2015, 7:95-103

Published Date: 30 January 2015

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece

Fragoulakis V, Vitsou E, Hernandez AC, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:85-93

Published Date: 16 January 2015

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece

Fragoulakis V, Raptis E, Vitsou E, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:73-83

Published Date: 8 January 2015

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population

Bonafede MM, Kalra VB, Miller JD, Fajardo LL

ClinicoEconomics and Outcomes Research 2015, 7:53-63

Published Date: 12 January 2015

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G

ClinicoEconomics and Outcomes Research 2015, 7:27-35

Published Date: 22 December 2014

Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

Schinco P, Cultrera D, Valeri F, Borchiellini A, Mantuano M, Gorla F, Savarese A, Teruzzi C

ClinicoEconomics and Outcomes Research 2015, 7:17-25

Published Date: 17 December 2014

The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?

Child DL, Cao Z, Seiberlich LE, Brown H, Greenberg J, Swanson A, Sewall MR, Robinson SB

ClinicoEconomics and Outcomes Research 2015, 7:1-8

Published Date: 15 December 2014

Level, pattern, and determinants of polypharmacy and inappropriate use of medications by village doctors in a rural area of Bangladesh

Rasu RS, Iqbal M, Hanifi SMA, Moula A, Hoque S, Rasheed S, Bhuiya A

ClinicoEconomics and Outcomes Research 2014, 6:515-521

Published Date: 3 December 2014

Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization

Perrone V, Conti V, Venegoni M, Scotto S, Degli Esposti L, Sangiorgi D, Prestini L, Radice S, Clementi E, Vighi G

ClinicoEconomics and Outcomes Research 2014, 6:505-514

Published Date: 3 December 2014

Measurement properties of painDETECT by average pain severity

Cappelleri JC, Bienen EJ, Koduru V, Sadosky A

ClinicoEconomics and Outcomes Research 2014, 6:497-504

Published Date: 6 November 2014

Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study

Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, Anschel A, Stacey BR, Nalamachu S, Nieshoff E

ClinicoEconomics and Outcomes Research 2014, 6:483-496

Published Date: 29 October 2014

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia

Shafie AA, Lim YW, Chua GN, Hassali MA

ClinicoEconomics and Outcomes Research 2014, 6:473-481

Published Date: 23 October 2014

Economic burden of asthma in Abu Dhabi: a retrospective study

Alzaabi A, Alseiari M, Mahboub B

ClinicoEconomics and Outcomes Research 2014, 6:445-450

Published Date: 17 October 2014

Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs

Bonafede MM, Miller JD, Laughlin-Tommaso SK, Lukes AS, Meyer NM, Lenhart GM

ClinicoEconomics and Outcomes Research 2014, 6:423-429

Published Date: 8 October 2014

Laparoscopic versus open colorectal resection for cancer and polyps: a cost-effectiveness study

Jordan J, Dowson H, Gage H, Jackson D, Rockall T

ClinicoEconomics and Outcomes Research 2014, 6:415-422

Published Date: 26 September 2014

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

ClinicoEconomics and Outcomes Research 2014, 6:409-414

Published Date: 23 September 2014

Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study

Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S

ClinicoEconomics and Outcomes Research 2014, 6:401-407

Published Date: 18 September 2014

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B

ClinicoEconomics and Outcomes Research 2014, 6:389-399

Published Date: 14 October 2014

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population

Bonafede M, Joseph GJ, Shah N, Princic N, Harrison DJ

ClinicoEconomics and Outcomes Research 2014, 6:381-388

Published Date: 15 September 2014

Economic burden associated with chronic constipation in Sweden: a retrospective cohort study

Bruce Wirta S, Hodgkins P, Joseph A

ClinicoEconomics and Outcomes Research 2014, 6:369-379

Published Date: 12 August 2014

Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia

Lin J, Li Y, Tian H, Goodman MJ, Gabriel S, Nazareth T, Turner SJ, Arcona S, Kahler KH

ClinicoEconomics and Outcomes Research 2014, 6:349-356

Published Date: 16 July 2014

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E

ClinicoEconomics and Outcomes Research 2014, 6:341-348

Published Date: 14 July 2014

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A

ClinicoEconomics and Outcomes Research 2014, 6:303-310

Published Date: 19 June 2014

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy

Menzin J, Sussman M, Munsell M, Zbrozek A

ClinicoEconomics and Outcomes Research 2014, 6:297-302

Published Date: 10 June 2014

Health economics evidence for medical nutrition: are these interventions value for money in integrated care?

Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H

ClinicoEconomics and Outcomes Research 2014, 6:241-252

Published Date: 19 May 2014

Dressing-related trauma: clinical sequelae and resource utilization in a UK setting

Charlesworth B, Pilling C, Chadwick P, Butcher M

ClinicoEconomics and Outcomes Research 2014, 6:227-239

Published Date: 28 April 2014

Respiratory syncytial virus: current and emerging treatment options

Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D Jr, Thompson R

ClinicoEconomics and Outcomes Research 2014, 6:217-225

Published Date: 25 April 2014

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting

Degli Esposti L, Saragoni S, Buda S, Degli Esposti E

ClinicoEconomics and Outcomes Research 2014, 6:209-216

Published Date: 22 April 2014

Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis

Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, Arcona S

ClinicoEconomics and Outcomes Research 2014, 6:197-208

Published Date: 10 April 2014

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children

Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A

ClinicoEconomics and Outcomes Research 2014, 6:187-196

Published Date: 8 April 2014

Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years

Karabis A, Mocarski M, Eijgelshoven I, Bergman G

ClinicoEconomics and Outcomes Research 2014, 6:175-185

Published Date: 5 April 2014

Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe

Toghanian S, DiBonaventura M, Järbrink K, Locklear JC

ClinicoEconomics and Outcomes Research 2014, 6:151-163

Published Date: 2 April 2014

Health economic analyses in medical nutrition: a systematic literature review

Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H

ClinicoEconomics and Outcomes Research 2014, 6:109-124

Published Date: 10 March 2014

The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam

Nguyen LT, Tran BX, Tran CT, Le HT, Tran SV

ClinicoEconomics and Outcomes Research 2014, 6:101-108

Published Date: 21 February 2014

Predictors of biologic treatment of psoriasis: a non-interventional study

Puig L, Fan T, Ding Q, Smith NE

ClinicoEconomics and Outcomes Research 2014, 6:93-100

Published Date: 17 February 2014

Duloxetine treatment adherence across mental health and chronic pain conditions

Able SL, Cui Z, Shen W

ClinicoEconomics and Outcomes Research 2014, 6:75-81

Published Date: 11 February 2014

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG

ClinicoEconomics and Outcomes Research 2014, 6:49-62

Published Date: 24 January 2014

Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer

Mislick K, Schonfeld W, Bodnar C, Tong KB

ClinicoEconomics and Outcomes Research 2014, 6:37-47

Published Date: 16 January 2014

Out-of-pocket cost of managing sick newborns in Enugu, southeast Nigeria

Ekwochi U, Osuorah DC, Ndu IK, Ezenwosu OU, Amadi OF, Nwokoye IC, Odetunde OI

ClinicoEconomics and Outcomes Research 2014, 6:29-35

Published Date: 16 January 2014

Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain

Darbà J, Kaskens L, Sánchez-de la Rosa R

ClinicoEconomics and Outcomes Research 2014, 6:1-9

Published Date: 16 December 2013

C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia

Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:611-621

Published Date: 3 December 2013

Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia

Liedgens H, Obradovic M, Nuijten M

ClinicoEconomics and Outcomes Research 2013, 5:597-609

Published Date: 25 November 2013

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C

ClinicoEconomics and Outcomes Research 2013, 5:565-573

Published Date: 18 November 2013

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M

ClinicoEconomics and Outcomes Research 2013, 5:545-553

Published Date: 18 October 2013

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL

ClinicoEconomics and Outcomes Research 2013, 5:507-517

Published Date: 24 October 2013

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

ClinicoEconomics and Outcomes Research 2013, 5:489-496

Published Date: 3 October 2013

Cost of noninfectious comorbidities in patients with HIV

Guaraldi G, Zona S, Menozzi M, Carli F, Bagni P, Berti A, Rossi E, Orlando G, Zoboli G, Palella F

ClinicoEconomics and Outcomes Research 2013, 5:481-488

Published Date: 23 September 2013

Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device

Grabner M, Chen Y, Nguyen M, Abbott SD, Quimbo R

ClinicoEconomics and Outcomes Research 2013, 5:471-479

Published Date: 23 September 2013

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A

ClinicoEconomics and Outcomes Research 2013, 5:459-470

Published Date: 13 September 2013

Early enteral nutrition in critical illness: a full economic analysis using US costs

Doig GS, Chevrou-Séverac H, Simpson F

ClinicoEconomics and Outcomes Research 2013, 5:429-436

Published Date: 23 August 2013

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study

Sicras-Mainar A, Díaz-Cerezo S, Sanz de Burgoa V, Navarro-Artieda R

ClinicoEconomics and Outcomes Research 2013, 5:419-427

Published Date: 19 August 2013

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H

ClinicoEconomics and Outcomes Research 2013, 5:407-418

Published Date: 14 August 2013

Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study

Bank AJ, Obetz C, Konrardy A, Khan A, Pillai KM, McKinley BJ, Gage RM, Turnbull MA, Kenney WO

ClinicoEconomics and Outcomes Research 2013, 5:399-406

Published Date: 9 August 2013

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B

ClinicoEconomics and Outcomes Research 2013, 5:355-367

Published Date: 11 July 2013

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A

ClinicoEconomics and Outcomes Research 2013, 5:347-354

Published Date: 9 July 2013

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Darbà J, Pérez-Álvarez N, Kaskens L, Holgado-Pérez S, Racketa J, Rejas J

ClinicoEconomics and Outcomes Research 2013, 5:327-336

Published Date: 5 July 2013

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D

ClinicoEconomics and Outcomes Research 2013, 5:317-325

Published Date: 8 July 2013

A cost-of-illness study of spina bifida in Italy

Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C

ClinicoEconomics and Outcomes Research 2013, 5:309-316

Published Date: 2 July 2013

The costs of traumatic brain injury: a literature review

Humphreys I, Wood RL, Phillips CJ, Macey S

ClinicoEconomics and Outcomes Research 2013, 5:281-287

Published Date: 26 June 2013

The clinical and economic burden of chronic obstructive pulmonary disease in the USA

Guarascio AJ, Ray SM, Finch CK, Self TH

ClinicoEconomics and Outcomes Research 2013, 5:235-245

Published Date: 17 June 2013

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Sorenson C, Drummond M, Bhuiyan Khan B

ClinicoEconomics and Outcomes Research 2013, 5:223-234

Published Date: 30 May 2013

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain

Llibre JM, Cardona G, Santos JR, Andreu A , Estrada JO, Ara J, Bonafont X, Clotet B

ClinicoEconomics and Outcomes Research 2013, 5:215-221

Published Date: 23 May 2013

Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany

Klussmann JP, Schädlich PK, Chen X, Rémy V

ClinicoEconomics and Outcomes Research 2013, 5:203-213

Published Date: 16 May 2013

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E

ClinicoEconomics and Outcomes Research 2013, 5:193-201

Published Date: 14 May 2013

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D

ClinicoEconomics and Outcomes Research 2013, 5:189-192

Published Date: 3 May 2013

Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S

ClinicoEconomics and Outcomes Research 2013, 5:171-180

Published Date: 23 April 2013

Update on the management of cirrhosis – focus on cost-effective preventative strategies

Neff GW, Kemmer N, Duncan C, Alsina A

ClinicoEconomics and Outcomes Research 2013, 5:143-152

Published Date: 12 April 2013

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E

ClinicoEconomics and Outcomes Research 2013, 5:125-135

Published Date: 11 April 2013

Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia

Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA

ClinicoEconomics and Outcomes Research 2013, 5:119-124

Published Date: 27 March 2013

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Mencacci C, Di Sciascio G, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:87-99

Published Date: 7 February 2013

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C

ClinicoEconomics and Outcomes Research 2013, 5:69-85

Published Date: 30 January 2013

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T

ClinicoEconomics and Outcomes Research 2013, 5:49-57

Published Date: 20 January 2013

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P

ClinicoEconomics and Outcomes Research 2013, 5:29-36

Published Date: 10 January 2013

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

Reynolds MR, Nilsson J, Åkerborg Ö, Jhaveri M, Lindgren P

ClinicoEconomics and Outcomes Research 2013, 5:19-28

Published Date: 8 January 2013

Epidemiology of falls and osteoporotic fractures: a systematic review

Morrison A, Fan T, Sen SS, Weisenfluh L

ClinicoEconomics and Outcomes Research 2013, 5:9-18

Published Date: 28 December 2012

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S

ClinicoEconomics and Outcomes Research 2012, 4:375-382

Published Date: 5 December 2012

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

Thorlund K, Druyts E, El Khoury AC, Mills EJ

ClinicoEconomics and Outcomes Research 2012, 4:349-359

Published Date: 16 November 2012

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

van Herick A, Schuetz CA, Alperin P, Bullano MF, Balu S, Gandhi S

ClinicoEconomics and Outcomes Research 2012, 4:337-347

Published Date: 9 November 2012

Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative

de Oliveira C, Wijeysundera HC, Tobe SW, Moy Lum-Kwong M, Von Sychowski S, Wang X, Tu JV, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:323-336

Published Date: 13 November 2012

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Granström O, Levin LA, Henriksson M

ClinicoEconomics and Outcomes Research 2012, 4:313-322

Published Date: 1 November 2012

Impact of dry eye on work productivity

Yamada M, Mizuno Y, Shigeyasu C

ClinicoEconomics and Outcomes Research 2012, 4:307-312

Published Date: 10 October 2012

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Walleser S, Ray J, Bischoff H, Vergnenègre A, Rosery H, Chouaid C, Heigener D, de Castro Carpeño J, Tiseo M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:269-275

Published Date: 14 September 2012

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

Rønborg SM, Svendsen UG, Micheelsen JS, Ytte L, Andreasen JN, Ehlers L

ClinicoEconomics and Outcomes Research 2012, 4:253-260

Published Date: 11 September 2012

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

ClinicoEconomics and Outcomes Research 2012, 4:245-252

Published Date: 5 September 2012

Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy

Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:237-243

Published Date: 3 September 2012

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T

ClinicoEconomics and Outcomes Research 2012, 4:227-235

Published Date: 23 August 2012

Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era

Catay E, Castel del Cid C, Narváez L, Velozo EJ, Rosa JE, Catoggio LJ, Soriano ER

ClinicoEconomics and Outcomes Research 2012, 4:219-225

Published Date: 23 August 2012

Burden of Crohn’s disease: economics and quality of life aspects in Italy

Benedini V, Caporaso N, Corazza GR, Rossi Z, Fornaciari G, Cottone M, Frosini G, Caruggi M, Ottolini C, Colombo GL

ClinicoEconomics and Outcomes Research 2012, 4:209-218

Published Date: 24 July 2012

Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece

Fragoulakis V, Kourlaba G, Tarlatzis B, Mastrominas M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:185-192

Published Date: 12 July 2012

Techniques for estimating health care costs with censored data: an overview for the health services researcher

Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:145-155

Published Date: 1 June 2012

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

Fragoulakis V, Kourlaba G, Goumenos D, Konstantoulakis M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:127-134

Published Date: 4 May 2012

Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection

Sacchi P, Patruno SFA, Bruno R, Cima SMB, Previtali P, Franchini A, Nicolini L, Rognoni C, Sacchi L, Bellazzi R, Filice G

ClinicoEconomics and Outcomes Research 2012, 4:117-126

Published Date: 11 May 2012

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Díaz de León-Castañeda C, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde MR, Moreno-Bonett C, Martínez-Núñez JM

ClinicoEconomics and Outcomes Research 2012, 4:57-65

Published Date: 7 March 2012

Treatment profiles and costs of patients with chronic pain in the population setting

Sicras Mainar A, Navarro Artieda R, Villoria Morillo J, Esquivias Escobar A

ClinicoEconomics and Outcomes Research 2012, 4:39-47

Published Date: 26 January 2012

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:31-37

Published Date: 26 January 2012

Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada

Tarride JE, Haq M, Taylor VH, Sharma AM, Nakhai-Pour HR,  O'Reilly D, Xie F, Dolovich L, Goeree R

ClinicoEconomics and Outcomes Research 2012, 4:21-30

Published Date: 24 January 2012

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

Ye W, Ascher-Svanum H, Flynn JA, Tanji Y, Takahashi M

ClinicoEconomics and Outcomes Research 2012, 4:13-19

Published Date: 13 January 2012

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines

Colombo GL, Colangeli V, Di Biagio A, Di Matteo S, Viscoli C, Viale P

ClinicoEconomics and Outcomes Research 2011, 3:197-205

Published Date: 31 October 2011

Corrigendum

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:187-188

Published Date: 6 September 2011

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Stafinski T, Menon D, Davis C, McCabe C

ClinicoEconomics and Outcomes Research 2011, 3:117-186

Published Date: 30 August 2011

The role of galenic innovation in improving treatment compliance and persistence: three case studies

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:109-116

Published Date: 4 August 2011

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM

ClinicoEconomics and Outcomes Research 2011, 3:79-87

Published Date: 20 April 2011

The economic burden of TNFα inhibitors and other biologic treatments in Norway

Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al

ClinicoEconomics and Outcomes Research 2011, 3:73-78

Published Date: 21 March 2011

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Giorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al

ClinicoEconomics and Outcomes Research 2011, 3:55-61

Published Date: 14 March 2011

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al

ClinicoEconomics and Outcomes Research 2011, 3:47-54

Published Date: 7 March 2011

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al

ClinicoEconomics and Outcomes Research 2011, 3:37-46

Published Date: 15 February 2011

Biosimilar medicines and cost-effectiveness

Steven Simoens

ClinicoEconomics and Outcomes Research 2011, 3:29-36

Published Date: 10 February 2011

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Sevket Ozkaya, Serhat Findik, Atilla Guven Atici

ClinicoEconomics and Outcomes Research 2011, 3:15-18

Published Date: 17 January 2011

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al

ClinicoEconomics and Outcomes Research 2011, 3:9-14

Published Date: 11 January 2011

The cost-effectiveness of venous-converted acid-base and blood gas status in pulmonary medical departments

Lars Oddershede, Sabrina Storgaard Petersen, Asgerd Krogh Kristensen, et al

ClinicoEconomics and Outcomes Research 2011, 3:1-7

Published Date: 16 December 2010

Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007

Jim E Banta, Ivorie Belk, Kedon Newton, et al

ClinicoEconomics and Outcomes Research 2010, 2:149-158

Published Date: 11 October 2010

On the decision rules of cost-effective treatment for patients with diabetic foot syndrome

John E Goulionis, Athanassios Vozikis, VK Benos, et al

ClinicoEconomics and Outcomes Research 2010, 2:121-126

Published Date: 17 August 2010

Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years

Luca Degli Esposti, Stefania Saragoni, Paolo Batacchi, et al

ClinicoEconomics and Outcomes Research 2010, 2:113-120

Published Date: 28 July 2010

The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis

Rikke Søgaard, Jan Sørensen, Louise Linde, et al

ClinicoEconomics and Outcomes Research 2010, 2:105-112

Published Date: 16 July 2010

Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population

Javier Mar, Isabel Larrañaga, Arantzazu Arrospide, et al

ClinicoEconomics and Outcomes Research 2010, 2:97-103

Published Date: 14 July 2010

Pharmacoeconomic considerations in the treatment of breast cancer

Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al

ClinicoEconomics and Outcomes Research 2010, 2:47-61

Published Date: 15 June 2010

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease

Shalini Naik, Khalid M Kamal, Patricia A Keys, et al

ClinicoEconomics and Outcomes Research 2010, 2:25-36

Published Date: 9 March 2010

Use of electronic medical records in oncology outcomes research

Gena Kanas, Libby Morimoto, Fionna Mowat, et al

ClinicoEconomics and Outcomes Research 2010, 2:1-14

Published Date: 24 February 2010

Economic considerations for bariatric surgery and morbid obesity

Eldo E Frezza, Mitchell Wacthell, Bradley Ewing

ClinicoEconomics and Outcomes Research 2009, 1:79-83

Published Date: 10 December 2009

Assessing cost-effectiveness in the management of multiple sclerosis

Ceri J Phillips, Ioan Humphreys

ClinicoEconomics and Outcomes Research 2009, 1:61-78

Published Date: 18 November 2009

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, et al.

ClinicoEconomics and Outcomes Research 2009, 1:53-59

Published Date: 15 October 2009

Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab

Francesco Patti, Angelo Pappalardo

ClinicoEconomics and Outcomes Research 2009, 1:45-51

Published Date: 21 August 2009

Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach

Jacobo Alejandro Gómez-Rico, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Rosario Cárdenas-Elizalde, Juan Carlos Hinojosa-Cruz, Consuelo Rubio-Poo

ClinicoEconomics and Outcomes Research 2009, 1:1-6

Published Date: 30 November 2008